Date Filed | Type | Description |
08/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
08/14/2023 |
SC 13G
| HIRSCHMAN ORIN reports a 5.4% stake in APYX MEDICAL CORPORATION |
08/10/2023 |
8-K
| Quarterly results |
05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
05/19/2023 |
SC 13G
| Divisadero Street Capital Management, LP reports a 5.9% stake in Apyx Medical Corporation |
05/12/2023 |
SC 13G
| HIRSCHMAN ORIN reports a 5.8% stake in APYX MEDICAL CORPORATION |
05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/11/2023 |
8-K
| Quarterly results |
04/18/2023 |
8-K
| Quarterly results |
03/16/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/16/2023 |
8-K
| Quarterly results |
03/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
02/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
02/14/2023 |
SC 13G/A
| PURA VIDA INVESTMENTS, LLC reports a 6.6% stake in APYX MEDICAL CORPORATION |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/11/2023 |
SC 13G/A
| Cowen Financial Products LLC reports a 5.1% stake in Apyx Medical Corp. |
01/10/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
12/05/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
12/02/2022 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
11/22/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
11/21/2022 |
SC 13G/A
| Archon Capital Management LLC reports a 10% stake in APYX MEDICAL CORPORATION |
08/17/2022 |
8-K
| Quarterly results |
08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/11/2022 |
8-K
| Quarterly results |
07/18/2022 |
8-K
| Quarterly results |
07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
06/24/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
06/13/2022 |
8-K
| Quarterly results |
05/27/2022 |
SD
| Form SD - Specialized disclosure report: |
05/26/2022 |
8-K
| Quarterly results |
05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/12/2022 |
8-K
| Quarterly results |
04/04/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
03/21/2022 |
8-K/A
| Appointed a new director |
|